Abstrato

SARS-CoV-2 mRNA vaccine associated myocarditis

Yakeeb Behedi

SARS-CoV-2 mRNA vaccines have played a pivotal role in combating the COVID-19 pandemic. However, the occurrence of myocarditis, an inflammation of the heart muscle, following vaccination has raised concerns. This article provides an overview of SARS-CoV-2 mRNA vaccine-associated myocarditis, focusing on its incidence, clinical presentation, and current understanding. Myocarditis following mRNA vaccination is rare, predominantly affecting young males. Symptoms typically emerge after the second vaccine dose and include chest pain, shortness of breath, and flu-like symptoms.